Anti-CACNA1F antibody [EPR11822] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal CACNA1F antibody. Carrier free. Suitable for Flow Cyt, WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
CACNAF1, CACNA1F, Voltage-dependent L-type calcium channel subunit alpha-1F, Voltage-gated calcium channel subunit alpha Cav1.4
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-CACNA1F antibody [EPR11822] - BSA and Azide free (AB249680)
This data was developed using ab171968, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of Y79 cells, labeling CACNA1F using ab171968 at a 1/100 dilution (red) or a rabbit IgG negative control (green).
- WB
Supplier Data
Western blot - Anti-CACNA1F antibody [EPR11822] - BSA and Azide free (AB249680)
This data was developed using ab171968, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-CACNA1F antibody [EPR11822] (<a href='/en-us/products/primary-antibodies/cacna1f-antibody-epr11822-ab171968'>ab171968</a>) at 1/1000 dilution
Lane 1:
A673 cell lysate at 10 µg
Lane 2:
Y79 cell lysate at 10 µg
Secondary
All lanes:
Standard HRP labeled goat anti-rabbit at 1/2000 dilution
Predicted band size: 219 kDa
true
Related conjugates and formulations (1)
-
Anti-CACNA1F antibody [EPR11822]
Reactivity data
Product details
ab249680 is the carrier-free version of ab171968.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The CACNA1F protein influences neurotransmitter release by regulating calcium entry which is essential for visual processing. It functions as a part of a larger voltage-gated calcium channel complex where its role is to fine-tune calcium signals. This precise control is necessary for the proper response to light stimuli in the eye allowing effective signal transmission to the visual pathways.
Pathways
The CACNA1F protein integrates into the calcium signaling pathway important for neuronal communication and sensory processes. It is also linked to the phototransduction cascade in the retina. Within these pathways CACNA1F interacts with related proteins like beta subunits that modulate the activity of the L-type calcium channels impacting overall visual function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Oxidative medicine and cellular longevity 2021:8379962 PubMed34630853
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com